Telehealth Abortion Care Provider Hey Jane Raises $6.1M
Overturning Roe v. Wade earlier this year left many people in shock, including businesses who had to navigate new state-by-state restrictions if they wanted to continue providing patients with access to safe abortion treatments. As anxiety kicked in for millions, New York City-based telehealth provider Hey Jane ramped up its virtual abortion care services. Now, with new funding, the company has its eyes set on expanding select services to all 50 states by the end of next year.
Hey Jane is a licensed telehealth platform that provides abortion care to insured and uninsured patients by delivering mifepristone and misoprostol, the two pills needed to terminate an unwanted pregnancy in patients less than 10 weeks into their pregnancy, via mail. The company saw its first patient in 2021 and has been helping others ever since.
On Wednesday, Hey Jane secured $6.1 million from “mission-aligned, female-founded funds,” including Ulu Ventures and The Helm, among others, Hey Jane CEO and co-founder Kiki Freedman wrote in a Medium post. With the new capital, the company’s total equity raised now stands at $9.7 million.
The Food and Drug Administration approved mail delivery for abortion pills during the Covid-19 pandemic. Since then, receiving abortion care via telehealth consultation and mailed medication has become popular among those seeking to terminate a pregnancy. Hey Jane said it has seen a 3x increase in patient demand for its abortion care services and has grown its clinical team by 5x over the past year.
“In a post-Roe world, innovation will be key in solving for access to abortion. Hey Jane is a lighthouse, not only for the individuals seeking medication abortion, but the companies following in their footsteps,” Lindsey Taylor Wood, a partner at The Helm, said in a statement.
In addition to providing virtual abortion care, Hey Jane offers holistic care for women. It also partners with abortion clinics to provide education on abortion care.
Built In previously caught up with the NYC company after the Roe v. Wade decision leaked. At the time, Hey Jane’s services were available in New York, California, Washington, Illinois, Colorado and New Mexico. The company has since expanded into New Jersey and Connecticut.
With the new funding, Hey Jane wants to provide care to more patients and plans to expand select services to patients in all 50 states. The company will also expand its team and launch treatment services for other conditions, such as postpartum depression and anxiety.